Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Monocyte Distribution Width As a Predictor of Alloimmunization in Patients Transfused with Red Blood Cells

Ashley Crosby, Emmanuel Fadeyi, Toyosi Onwuemene, Amit Kumar Saha, Gregory J. Pomper, Danielle Maracaja

Blood (2024) 144 (Supplement 1): 5604.

https://doi.org/10.1182/blood-2024-209233

Published: 2024

Journal Articles

The Exportin, CSE1L, Regulates Ribosome Biogenesis and Is a Selective Dependency in Childhood and Young Adult Acute Myeloid Leukemia

Grace Egan, Amit Kumar, Veronique Voisin, Rose Hurren, Ali Chegini, Dakai Ling, Geethu Emily Thomas, Youngran Yan, Yue Feng, Suraj Bansal, Andy G.X. Zeng, Andrea Arruda, John Edgar Dick, Gary D Bader, Mark D. Minden, Aaron D Schimmer

Blood (2024) 144 (Supplement 1): 2724.

https://doi.org/10.1182/blood-2024-200148

Published: 2024

Journal Articles

Validation of a Novel Rac1 Inhibitor As Potent Secdrug Against Activating Ras Mutant and Drug-Resistant Multiple Myeloma

Salsabil Ahmed, Suman Mazumder, Lisa Wiesen, Neeraj Sharma, Ujjal Kumar Mukherjee, Shaji K Kumar, Linda B. Baughn, Brian G. Van Ness, Amit Kumar Mitra

Blood (2022) 140 (Supplement 1): 4249–4250.

https://doi.org/10.1182/blood-2022-164501

Published: 2022

Journal Articles

Synergism between IGF2BP1 and ETV6-RUNX1 in the Pathogenesis of ETV6-RUNX1 Positive B-Acute Lymphoblastic Leukaemia

Gunjan Sharma, Tiffany Tran, Jaspal Bassi, Amit Kumar Jaiswal, Christine Tso, Ayushi Jain, Jay Singh, Anita Chopra, Archna Singh, Sameer Bakhshi, Dinesh S Rao, Jayanth Kumar Palanichamy

Blood (2021) 138 (Supplement 1): 3483.

https://doi.org/10.1182/blood-2021-150319

Published: 2021

Journal Articles

The Anti-Leprosy Drug Clofazimine Synergizes with BTK Inhibitors and Proteasome Inhibitors in Drug-Resistant Mantle Cell Lymphoma

Sayak Chakravarti, Harish Kumar, Suman Mazumder, Sabyasachi Sanyal, Brian G. Van Ness, Amit Kumar Mitra

Blood (2021) 138 (Supplement 1): 1190.

https://doi.org/10.1182/blood-2021-154377

Published: 2021

Journal Articles

In silico Prediction Followed By I n Vitro validation Identifies a Survivin Inhibitor and an MCL-1 Inhibitor As a Potent Secondary Drug Against Refractory or Relapsed Mantle Cell Lymphoma

Sayak Chakravarti, Ujjal Kumar Mukherjee, Suman Mazumder, Timothy Moore, Amit Kumar Mitra

Blood (2021) 138 (Supplement 1): 1191.

https://doi.org/10.1182/blood-2021-154479

Published: 2021

Journal Articles

Establishing a Novel Pipeline That Combines in-Silico Prediction with in-Vitro and Ex-Vivo V alidation to Discover Secondary Drug Combinations Against Relapsed and/or Refractory Multiple Myeloma

Sayak Chakravarti, Suman Mazumder, Harish Kumar, Neeraj Sharma, Ujjal Kumar Mukherjee, Shaji Kumar, Linda B Baughn, Brian G. Van Ness, Amit Kumar Mitra

Blood (2021) 138 (Supplement 1): 1615.

https://doi.org/10.1182/blood-2021-154521

Published: 2021

Journal Articles

The RNA Binding Protein IGF2BP3 Is Required for MLL-AF4 Mediated Leukemogenesis

Tiffany Tran, BS, Jaspal Bassi, Neha Nibber, Julia Philipp, Jolene Draper, Tasha Lin, MD, Jayanth Kumar Palanichamy, MDMBBS, Amit Kumar, Oscar Silva, MD PhD, May Paing, Jennifer King, MD, Sol Katzman, Jeremy Sanford, Dinesh S. Rao, MD PhD

Blood (2020) 136 (Supplement 1): 21–22.

https://doi.org/10.1182/blood-2020-143181

Published: 2020

Journal Articles

Repurposing Clofazimine As a Novel Drug for the Treatment of PI-Resistant Stem Cell-like Subclones in Myeloma

Harish Kumar, PhD, Ujjal Kumar Mukherjee, PhD, Suman Mazumder, PhD, Sabyasachi Sanyal, PhD, Brian G. Van Ness, PhD, Amit Kumar Mitra, PhD MSc, BSc

Blood (2019) 134 (Supplement_1): 4418.

https://doi.org/10.1182/blood-2019-131596

Published: 2019

Journal Articles

In silico Prediction Followed By in Vitro validation Identifies the Survivin Inhibitor YM155 As a Potent Secondary Drug Against Pi-Resistant Myeloma

Harish Kumar, PhD, Ujjal Kumar Mukherjee, PhD, Li Chen, PhD, Amit Kumar Mitra, PhD MSc, BSc

Blood (2019) 134 (Supplement_1): 5543.

https://doi.org/10.1182/blood-2019-131923

Published: 2019

Journal Articles

Pre-Transplant Use of Tyrosine Kinase Inhibitors Increases Risk of Transplant Associated Thrombotic Microangiopathy - a Single Centre Analysis of Incidence, Risk Factors and Outcomes

Siddhesh Arun Kalantri, MD, Akanksha Chichra, DNB, Amit Kumar Agrawal, MDMDcine, Lingaraj Nayak, MDDM MDcal Oncology, Avinash Bonda, MD DM, Sachin Punatar, MBBS,MDDM MDcal Oncology, Anant Gokarn, MD, Bhausaheb Bagal, MD DM, Libin J Mathew, Sadhana Kannan, MSc, Navin Khattry, MD DM MDcal Oncology

Blood (2019) 134 (Supplement_1): 1983.

https://doi.org/10.1182/blood-2019-125029

Published: 2019

Journal Articles

Secdrug: A Computational Method for Discovering Novel Secondary Drug Combinations Using Large-Scale Pharmacogenomics Databases

Li Chen, PhD, Ujjal Kumar Mukherjee, PhD, Emily Rankine, Brian G. Van Ness, PhD, Amit Kumar Mitra, PhD

Blood (2018) 132 (Supplement 1): 4473.

https://doi.org/10.1182/blood-2018-99-117653

Published: 2018

Journal Articles

Gene Expression Profiling of Kinetic Response to Proteasome Inhibitors in Innate and Acquired Resistant Multiple Myeloma

Amit Kumar Mitra, PhD, Vijay G. Ramakrishnan, PhD, Shaji K Kumar, MD, S. Vincent Rajkumar, MD, Brian G. Van Ness, PhD

Blood (2017) 130 (Supplement 1): 4405.

https://doi.org/10.1182/blood.V130.Suppl_1.4405.4405

Published: 2017

Journal Articles

Scattome: A Single-Cell Analysis of Targeted Transcriptome Program to Predict Drug Sensitivity of Single Cells within Human Myeloma Tumors

Amit Kumar Mitra, PhD, Ujjal Mukherjee, PhD, Taylor Harding, Holly Stessman, PhD, Ying Li, Jen Jin, Shaji K Kumar, MD, S. Vincent Rajkumar, Brian G Van Ness, PhD

Blood (2015) 126 (23): 4249.

https://doi.org/10.1182/blood.V126.23.4249.4249

Published: 2015

Journal Articles

Creation of a Gene Expression Signature-Based Prediction Model Specific to Proteasome Inhibitor Response in Multiple Myeloma

Amit Kumar Mitra, PhD, Ujjal Mukherjee, PhD, Taylor Harding, Snigdhansu Chatterjee, PhD, Brian G Van Ness, PhD

Blood (2015) 126 (23): 3053.

https://doi.org/10.1182/blood.V126.23.3053.3053

Published: 2015

Journal Articles

Single-Cell Transcriptomics Identifies Intra-Tumor Heterogeneity in Human Myeloma Cell Lines

Amit Kumar Mitra, PhD, Holly Stessman, PhD, Michael A. Linden, MDPhD, Brian Van Ness, PhD

Blood (2014) 124 (21): 3385.

https://doi.org/10.1182/blood.V124.21.3385.3385

Published: 2014

Journal Articles

Comparative Analysis of in Vitro Chemosensitivity to Four Proteasome Inhibitors in Human Myeloma Cell Lines

Amit Kumar Mitra, PhD, Taylor S Harding, B.A., Brian Van Ness, PhD

Blood (2014) 124 (21): 3436.

https://doi.org/10.1182/blood.V124.21.3436.3436

Published: 2014

Journal Articles

Generation of a Predictive Score for Ixazomib Response in Multiple Myeloma

Amit Kumar Mitra, PhD, Sanjoy Dey, Andrew Hangsleben, Michael Steinbach, Vipin Kumar, PhD, Brian Van Ness, PhD

Blood (2014) 124 (21): 5695.

https://doi.org/10.1182/blood.V124.21.5695.5695

Published: 2014

Journal Articles

White Blood Cell Mechanics Mediate Glucocorticoid- and Catecholamine-Induced Demargination

Meredith E Fay, David R Myers, PhD, Amit Kumar, PhD, Rebecca Byler, Todd A Sulchek, PhD, Michael D Graham, PhD, Wilbur A Lam, MD, PhD

Blood (2013) 122 (21): 3459.

https://doi.org/10.1182/blood.V122.21.3459.3459

Published: 2013

Journal Articles

Intravascular Large B-Cell Lymphoma (IVLBCL): A Study of 12 Cases with Special Emphasis on High Density Lipoprotein Cholesterol (HDL-C) Preceding Diagnosis

Amit Kumar Garg, MD, David M. Baer, MD, Elizabeth Hosfield, MD

Blood (2011) 118 (21): 5221.

https://doi.org/10.1182/blood.V118.21.5221.5221

Published: 2011

NARROW

Monocyte Distribution Width As a Predictor of Alloimmunization in Patients Transfused with Red Blood Cells

The Exportin, CSE1L, Regulates Ribosome Biogenesis and Is a Selective Dependency in Childhood and Young Adult Acute Myeloid Leukemia

Validation of a Novel Rac1 Inhibitor As Potent Secdrug Against Activating Ras Mutant and Drug-Resistant Multiple Myeloma

Synergism between IGF2BP1 and ETV6-RUNX1 in the Pathogenesis of ETV6-RUNX1 Positive B-Acute Lymphoblastic Leukaemia

The Anti-Leprosy Drug Clofazimine Synergizes with BTK Inhibitors and Proteasome Inhibitors in Drug-Resistant Mantle Cell Lymphoma

In silico Prediction Followed By I n Vitro validation Identifies a Survivin Inhibitor and an MCL-1 Inhibitor As a Potent Secondary Drug Against Refractory or Relapsed Mantle Cell Lymphoma

Establishing a Novel Pipeline That Combines in-Silico Prediction with in-Vitro and Ex-Vivo V alidation to Discover Secondary Drug Combinations Against Relapsed and/or Refractory Multiple Myeloma

The RNA Binding Protein IGF2BP3 Is Required for MLL-AF4 Mediated Leukemogenesis

Repurposing Clofazimine As a Novel Drug for the Treatment of PI-Resistant Stem Cell-like Subclones in Myeloma

In silico Prediction Followed By in Vitro validation Identifies the Survivin Inhibitor YM155 As a Potent Secondary Drug Against Pi-Resistant Myeloma

Pre-Transplant Use of Tyrosine Kinase Inhibitors Increases Risk of Transplant Associated Thrombotic Microangiopathy - a Single Centre Analysis of Incidence, Risk Factors and Outcomes

Secdrug: A Computational Method for Discovering Novel Secondary Drug Combinations Using Large-Scale Pharmacogenomics Databases

Gene Expression Profiling of Kinetic Response to Proteasome Inhibitors in Innate and Acquired Resistant Multiple Myeloma

Scattome: A Single-Cell Analysis of Targeted Transcriptome Program to Predict Drug Sensitivity of Single Cells within Human Myeloma Tumors

Creation of a Gene Expression Signature-Based Prediction Model Specific to Proteasome Inhibitor Response in Multiple Myeloma

Single-Cell Transcriptomics Identifies Intra-Tumor Heterogeneity in Human Myeloma Cell Lines

Comparative Analysis of in Vitro Chemosensitivity to Four Proteasome Inhibitors in Human Myeloma Cell Lines

Generation of a Predictive Score for Ixazomib Response in Multiple Myeloma

White Blood Cell Mechanics Mediate Glucocorticoid- and Catecholamine-Induced Demargination

Intravascular Large B-Cell Lymphoma (IVLBCL): A Study of 12 Cases with Special Emphasis on High Density Lipoprotein Cholesterol (HDL-C) Preceding Diagnosis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only